GHDx
Published on GHDx (https://ghdx.healthdata.org)


Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

General Info

Geography 
Australia (AUS)
Austria (AUT)
Belgium (BEL)
Denmark (DNK)
Finland (FIN)
France (FRA)
Germany (DEU)
Greece (GRC)
Ireland (IRL)
Italy (ITA)
Netherlands (NLD)
New Zealand (NZL)
Norway (NOR)
Portugal (PRT)
Spain (ESP)
Sweden (SWE)
Switzerland (CHE)
United Kingdom (GBR)
View all
Time period covered 
January, 2000 - December, 2011
Data type
Scientific literature
Keywords 
Chemotherapy, Health care costs, Multiple myeloma

Citation

Authors 
Vogler S, Vitry A, Babar ZU
Journal 
Lancet Oncol
Pages 
39-47
Publication year 
2016
Suggested citation 
Vogler S, Vitry A, Babar ZU. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncol. 2016; 17(1): 39-47.

Source URL:https://ghdx.healthdata.org/record/cancer-drugs-16-european-countries-australia-and-new-zealand-cross-country-price-comparison